ERIKA NEGRO: Open Payments
NPI 1194447730 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 21 payments from 15 companies in 2025. Trend: 2023 $909 · 2024 $735 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $128 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| LivaNova USA, Inc. | 1 | $109 |
| Mallinckrodt Hospital Products Inc. | 2 | $68 |
| UCB, Inc. | 1 | $38 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Merz Pharmaceuticals, LLC | 1 | $28 |
| Genentech USA, Inc. | 1 | $27 |
Products named: KESIMPTA, EPIDIOLEX, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, ACTHAR, Fintepla, PONVORY, Xeomin, Ocrevus Zunovo.
Industry payments across FL — which companies pay providers there.
